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Chromosome folding has been long associated with gene expression. Articles in Cell Stem Cell and Cell by
Apostolou et al., (2013), Phillips-Cremins et al., (2013),Wei et al., (2013), and Zhang et al., (2013) uncover chro-
matin interaction networks linked to the establishment or maintenance of pluripotency and identify some
responsible factors.The promise of stem cell therapies has
been profoundly advanced by the seminal
finding that differentiated cells can be re-
programmed to pluripotent stem cells by
overexpression of a cocktail of transcrip-
tion factors (Takahashi and Yamanaka,
2006). However this process is very ineffi-
cient, and understanding the barriers to
reprogramming has become an intense
area of study. The 3D organization of the
genome is correlated with transcriptional
control; for example, chromatin loops
bring enhancers into physical proximity
with their gene targets (Kagey et al.,
2010) and coregulated genes occupy
shared nuclear foci, enriched in key
transcription factors (Schoenfelder et al.,
2010) specifically in the cell types where
the genes are expressed. Four recent
studies have analyzed the chromatin
interactions with key pluripotency genes
in mouse and human pluripotent and
differentiated cells, and they have uncov-
ered networks of interactions that are
specific to embryonic stem cells (ESCs)
or induced pluripotent stem cells (iPSCs).
One of the recent studies showed
that binding of overexpressed OCT4
and NANOG at gene loci was identical
between human iPSCs and unreprog-
rammed cells from the same experiment,
but that enhancer-promoter loops within
OCT4, SOX2, and NANOG loci were
specific to iPSCs, concomitant with tran-
scription from these endogenous loci
(Zhang et al., 2013). Looking more sys-
tematically, two groups assessed chro-
matin interactions genome-wide with
the pluripotency genes Nanog or Oct4
(Apostolou et al., 2013; Wei et al., 2013),
and another simultaneously screened
the chromatin conformations around
several key loci (Phillips-Cremins et al.,
2013) in mouse ESCs and their differ-
entiated counterparts. Again, a set ofenhancer-promoter loops and longer-
range (over several megabases or across
different chromosomes) gene coassocia-
tions were unique to pluripotent cells or
intermediates being successfully reprog-
rammed to iPSCs, despite equal binding
profiles of the overexpressed transcrip-
tion factors.
Because gene-centric chromatin inter-
actions frequently correlate with expres-
sion of a given gene (Kagey et al., 2010;
Schoenfelder et al., 2010), an open ques-
tion is whether such genomic topologies
are a functional cause or a mere byprod-
uct of transcription. Time course studies
of the gain or loss of pluripotency-linked
chromatin interactions during iPSC
generation (Wei et al., 2013) or ESC
differentiation (Apostolou et al., 2013)
found detectable changes in the chro-
matin interactions days before tran-
scriptional changes and differentiation
phenotypes were observed. Although
these data suggest a causal link
between chromosome contact estab-
lishment and gene activation, earlier
experiments showed that artificially
induced enhancer-promoter looping was
able to stimulate weak transcription of
the beta-globin gene in erythroid cells
lacking a hematopoietic transcription
factor (Deng et al., 2012), indicating that
a permissive genome topology is required
but not sufficient to induce transcriptional
activation. Formation of the transcription-
ally permissive chromatin interactions
with pluripotency gene loci appears to
distinguish the small number of cells
able to be reprogrammed to iPSCs from
the nonprogrammable cells (Zhang et al.,
2013), suggesting that this may form the
‘‘epigenetic barrier’’ to pluripotency. Simi-
larly, activation of beta-globin by a heter-
ologous enhancer inserted on a different
chromosome is restricted to a smallCell Stemnumber of ‘‘jackpot’’ cells in the popula-
tion (Noordermeer et al., 2011). Although
these data were generated using two
artificial systems, they suggest a model
where chance chromatin interactions
allow transient or inefficient transcrip-
tional activation by bringing together a
hub of regulatory factors (Figure 1). Pro-
gressive stabilization of these interactions
and/or additional factors then commit the
gene to efficient transcription, perhaps
creating a sufficiently permissive environ-
ment to allow transcription to occur in the
absence of the initiating chromatin inter-
actions (Wei et al., 2013). The detection
of pluripotency-gene-linked chromatin
interactions specific to partially reprog-
rammed intermediate iPSCs (Apostolou
et al., 2013) is consistent with the idea of
a progressive search for a functional
genome configuration. It will be inter-
esting to see if such a model can explain
gene expression control in normal differ-
entiation and how it would differ for genes
subject to more acute transcriptional
changes, such as the immediate early
genes upon mitogenic stimulation.
Previous research has implicated
several protein factors to be respon-
sible for chromatin interactions. Protein-
protein interactions among transcription
factors bound to promoters and en-
hancers stimulate chromatin looping
(Deng et al., 2012) and longer-range coas-
sociations (Schoenfelder et al., 2010), and
more general, non-cell-type-specific fac-
tors have also been implicated in genome
folding. These include the insulator-bind-
ing protein CTCF (Splinter et al., 2006),
the cohesin complex that mediates sister
chromatid cohesion (Kagey et al., 2010),
and the transcriptional coactivator com-
plex, Mediator (Kagey et al., 2010). Again,
demonstrating a causal relationship
between binding of these proteins andCell 13, July 3, 2013 ª2013 Elsevier Inc. 3
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Figure 1. Model for the Role of Chromatin Interactions in Mediating
Pluripotency
Overexpressed Yamanaka transcription factors (blue ovals) bind to motifs at
the promoters and enhancers of pluripotency genes (purple rectangles) in
differentiated tissues (left panel), but very few are reprogrammed to iPSCs.
Chance chromatin interactions between enhancers and promoters, and be-
tween pluripotency genes, seem to be required for reprogramming (right
panel), and are reinforced by further recruitment of the ‘‘architectural proteins’’
Mediator (yellow squares) and cohesin rings (orange circles), providing a
permissive environment for transcriptional activation of the pluripotency
genes.
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has been difficult (Deng et al.,
2012). Collectively, the four
recent studies shed further
light on the interplay between
transcription factors and the
‘‘architectural’’ proteins in
establishing functional chro-
matin interactions. Phillips-
Cremins et al. (2013), in the
most detailed analysis of
genome folding around several
pluripotency gene loci, reveal
that chromatin loops are prev-
alently formed around binding
sites of the architectural pro-
teins cohesin, CTCF, and/or
Mediator, with significantly
less contribution from the
binding sites of the pluripo-
tency transcription factors
Oct4, Sox2, and Nanog. Inter-
estingly, by comparing ESC
and neural precursor interac-
tion profiles, the authors
were able to distinguish twogeneral classes of chromatin loops:
ESC-specific enhancer-promoter loops,
coinciding with cohesin/Mediator bind-
ing, and often transcription factor binding,
but without CTCF; and larger, constitutive
loops coinciding with CTCF and cohesin
binding sites, proposed to play a more
fundamental architectural role in chromo-
some folding. The other three articles
highlighted here studied the interplay
between transcription factors and archi-
tectural proteins in more detail. Knock-
down of pluripotency transcription
factors, for instance Klf4 (Wei et al.,
2013) or cohesin or Mediator (Apostolou
et al., 2013; Kagey et al., 2010; Zhang
et al., 2013), induces differentiation of
ESCs or impairs reprogramming to form
iPSCs. However, whereas transcription
factors were able to bind in both pluri-
potent and nonreprogrammed cells, the
binding of cohesin and/or Mediator was
exclusive to cells with a ‘‘pluripotency
competent’’ genome configuration (Wei
et al., 2013; Zhang et al., 2013). These
findings suggest that the epigenetic bar-
rier to pluripotency may be the establish-
ment of permissive chromatin interactions
by recruitment of cohesin and/orMediator
(Figure 1), which in some cases may be
mediated by direct protein-protein inter-
actions with sequence-specific trans-
cription factors (Wei et al., 2013). While4 Cell Stem Cell 13, July 3, 2013 ª2013 Elsevindirect effects, such as cell cycle pertur-
bation on cohesin knockdown, cannot be
excluded when interpreting these experi-
ments, this combined body of work sug-
gests an attractive mechanism whereby
stochastic permissive chromatin interac-
tions can be stabilized by architectural
proteins, allowing nuclear programming
during differentiation or establishment of
pluripotency. Within this context, the
possibility that interactions between
pluripotency factors or architectural com-
ponents may induce posttranslational
modifications in order to stabilize pluripo-
tent chromatin configuration remains to
be considered.
As cohesin and Mediator do not
have sequence-specific binding pro-
perties, understanding their recruitment
to genomic locations other than known
binding sites for the pluripotency tran-
scription factors will also be important to
understand the modulation of nuclear ar-
chitecture. Transcription factors beyond
those studied here may generally function
by recruitment of these factors or archi-
tectural proteins yet to be discovered.
Moreover, it will be important to investi-
gate the role of the multiple pluripotency
transcription factor binding sites that
have not been shown to coassociate
with architectural proteins and do not
participate in chromatin loops. They mayier Inc.either be involved in loops
at cell states that have not
yet been investigated, or they
may function in different
mechanisms to maintain plu-
ripotency. Finally, these
studies highlighted gene loop
formation for transcriptional
activation, but programmed
gene loops may be equally
important in order to mask dif-
ferentiation-specific genes in
ESCs or during reprogramming
to iPSCs, an issue that remains
open for future studies.ACKNOWLEDGMENTS
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